Drug Type Small molecule drug |
Synonyms Aerinaze, Clarinex-D |
Mechanism ADRA1 agonists(Adrenergic receptor alpha-1 agonists), ADRA2 agonists(Adrenergic receptors alpha-2 agonists), H1 receptor antagonists(Histamine H1 receptor antagonists) + [3] |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (03 Mar 2005), |
Regulation- |
Molecular FormulaC10H17NO5S |
InChIKeyXVPDSDYVNYOVMP-KXNXZCPBSA-N |
CAS Registry7460-12-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Rhinitis, Allergic, Seasonal | US | 03 Mar 2005 |